<SEC-DOCUMENT>0001641172-25-013164.txt : 20250530
<SEC-HEADER>0001641172-25-013164.hdr.sgml : 20250530
<ACCEPTANCE-DATETIME>20250530215807
ACCESSION NUMBER:		0001641172-25-013164
CONFORMED SUBMISSION TYPE:	3/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250429
FILED AS OF DATE:		20250530
DATE AS OF CHANGE:		20250530

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			SURIA SUKSES ENGINEERING SDN BHD
		CENTRAL INDEX KEY:			0002044793
		ORGANIZATION NAME:           	
		STATE OF INCORPORATION:			N8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50626
		FILM NUMBER:		251012947

	BUSINESS ADDRESS:	
		STREET 1:		L-3-E-8, ENTERPRISE 4
		STREET 2:		TAMAN TEKNOLOGI MRANTI BUKIT JALIL
		CITY:			KUALA LUMPUR
		STATE:			N8
		ZIP:			57000
		BUSINESS PHONE:		6012-2237897

	MAIL ADDRESS:	
		STREET 1:		L-3-E-8, ENTERPRISE 4
		STREET 2:		TAMAN TEKNOLOGI MRANTI BUKIT JALIL
		CITY:			KUALA LUMPUR
		STATE:			N8
		ZIP:			57000

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218
</SEC-HEADER>
<DOCUMENT>
<TYPE>3/A
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3/A</documentType>

    <periodOfReport>2025-04-29</periodOfReport>

    <dateOfOriginalSubmission>2025-05-02</dateOfOriginalSubmission>

    <noSecuritiesOwned>1</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001130166</issuerCik>
        <issuerName>Cyclacel Pharmaceuticals, Inc.</issuerName>
        <issuerTradingSymbol>CYCC</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0002044793</rptOwnerCik>
            <rptOwnerName>SURIA SUKSES ENGINEERING SDN BHD</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>26-13A STELLAR SUITES, JALAN</rptOwnerStreet1>
            <rptOwnerStreet2>PUTERI 4/7, BANDAR PUTERI</rptOwnerStreet2>
            <rptOwnerCity>PUCHONG SELANGOR,</rptOwnerCity>
            <rptOwnerState>N8</rptOwnerState>
            <rptOwnerZipCode>47100</rptOwnerZipCode>
            <rptOwnerStateDescription>MALAYSIA</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>1</isOther>
            <officerTitle></officerTitle>
            <otherText>Shareholder</otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <remarks>This Form 3 amendment is being filed to correct the original Form 3 filed on May 2, 2025 which was filed in error as the Reporting Person is not an officer, director or ten percent owner of the outstanding shares of common stock of Cyclacel Pharmaceuticals, Inc. and therefore not obligated to file a Form 3. The Reporting Person is not voluntarily subjecting itself to Section 16 reporting. Chen Choon Seng, the authorized representative of the Reporting Person has been deputized to represent the Reporting Person.</remarks>

    <ownerSignature>
        <signatureName>/s/ Chen Choon Seng</signatureName>
        <signatureDate>2025-05-30</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
